Grant: Discovery Grants Program - Individual
McGill University
$30,000.00
Study of the vesicular monoamine transporter: role and function
FY 2011-12
Summary
Synthesized in restricted nuclei, dopamine (DA) is a major neuromodulator in the mammal brain. To understand how this molecule can regulates various superior brain functions, it is essential to have a comprehensive knowledge of the processes involved in establishing and controlling the DA synaptic fluxes. The Vesicular Monoamine Transporter type 2 (VMAT2) is the key proteins that accumulates DA into synaptic vesicles for (Ca++)-dependent release.
We speculate that protein-protein interactions that take place within the interactomes for this vesicular monoamine transporter is essential for regulating DA fluxes. Using complementary approaches Yeast 2-hybrid, in-vivo TAP-Tag) we would like to precisely identify the protein partners involved in these interactions, and to characterize the mechanisms and the physiology of these interactions.
In parallel, we have develop a unique model for the conditional knock-out of the VMAT2, that will also help us to better understand the respective role of this transporter in dopamine, serotoninen, and adrenergic systems.
We believe that this 5 year project, for which an important number of preliminary experiments have been already performed, is original and ambitious. By combining various and complementary approaches, we expect that we may evaluate, for the first time using in vitro and in vivo approaches, the physiological role and the function of proteins that directly interact with the vesicular dopamine transporters.
Program
Discovery Grants Program - Individual
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
385732-2011
Name nom
Giros, Bruno
Department département
Psychiatry
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2011
Award amount
30000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
5400
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Biochemistry
Research subject fr
Biochimie
Partie
1
Nb partie
1
Application title
Study of the vesicular monoamine transporter: role and function
Keyword
NSERC
Application summary
Synthesized in restricted nuclei, dopamine (DA) is a major neuromodulator in the mammal brain. To understand how this molecule can regulates various superior brain functions, it is essential to have a comprehensive knowledge of the processes involved in establishing and controlling the DA synaptic fluxes. The Vesicular Monoamine Transporter type 2 (VMAT2) is the key proteins that accumulates DA into synaptic vesicles for (Ca++)-dependent release.
We speculate that protein-protein interactions that take place within the interactomes for this vesicular monoamine transporter is essential for regulating DA fluxes. Using complementary approaches Yeast 2-hybrid, in-vivo TAP-Tag) we would like to precisely identify the protein partners involved in these interactions, and to characterize the mechanisms and the physiology of these interactions.
In parallel, we have develop a unique model for the conditional knock-out of the VMAT2, that will also help us to better understand the respective role of this transporter in dopamine, serotoninen, and adrenergic systems.
We believe that this 5 year project, for which an important number of preliminary experiments have been already performed, is original and ambitious. By combining various and complementary approaches, we expect that we may evaluate, for the first time using in vitro and in vivo approaches, the physiological role and the function of proteins that directly interact with the vesicular dopamine transporters.